Disorders of skin barriers: Clinical implications

Journal of the European Academy of Dermatology and Venereology

Volumn 16, Issue 6, 2002, Pages 559-561

  Berardesca, E ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CERAMIDE DERIVATIVE; CHOLESTEROL; CHOLESTEROL SULFATE; EPIDERMAL GROWTH FACTOR; ESSENTIAL FATTY ACID; FATTY ACID; FILAGGRIN; GLYCEROL; GLYCOSPHINGOLIPID; HYDROXYACID; IMMUNOGLOBULIN E; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INVOLUCRIN; KERATIN; KERATOHYALIN; LINOLEIC ACID; LIPID; LORICRIN; PALMITIC ACID; PETROLATUM; PHOSPHOLIPID; PROFILAGGRIN; PYROGLUTAMIC ACID; STEARIC ACID; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ATOPIC DERMATITIS; BILAYER MEMBRANE; CONGENITAL ICHTHYOSIFORM ERYTHRODERMA; DESQUAMATION; DRUG MECHANISM; DRY SKIN; EDITORIAL; EPIDERMIS CELL; EPIDERMOLYSIS BULLOSA; IRRITANT DERMATITIS; KERATOSIS PALMOPLANTARIS; MOUSE; NONHUMAN; PARAKERATOSIS; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; SKIN DEFECT; SKIN DISEASE; SKIN FUNCTION; SKIN INFLAMMATION; SKIN SENSITIZATION; SKIN WATER LOSS; STRATUM CORNEUM; XEROSIS;

DERMATITIS, ATOPIC; HUMANS; INTERMEDIATE FILAMENTS; KERATINS; SKIN DISEASES; SKIN PHYSIOLOGY;

EID: 0036853716     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2002.00528.x     Document Type: Editorial

References (14)

1. Schaefer H, Redelmeier TE, editors. Skin Barrier Principles of Percutaneous Absorption. Karger, Basel, 1966.
2. Wehidenthaler B, Hauser I, Anton-Lamprecht I. Is filaggrin really a filament-aggregating protein in vivo? Arch Dermatol Res 1993; 285: 111-120.
3. Yaffe MB, Beegen H, Eckert RL. Biophysical characterization of involucrin reveals a molecule ideally suited to function as an intermolecular cross-bridge of the keratinocyte cornified envelope. J Biol Chem 1992; 267: 12233-12238.
4. Schurer NY, Elias PM. The biochemistry and function of stratum corneum lipids. Adv Lipid Res 1991; 24: 27-56.
5. Elias PM, Feingold KR. Lipids and the epidermal water barrier: metabolism, regulation, and pathophysiology. Semin Dermatol 1992; 11: 176-182.
6. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98: 279-289.
7. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991; 24: 1-26.
8. Murata Y, Ogata J, Higaki Y et al. Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency? J Invest Dermatol 1996; 106: 1242-1249.
9. Wood LC, Jackson SM, Elias PM et al. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 1992; 90: 482-487.
10. Elias PM, Wood LC, Feingold KR. Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 1999; 10: 119-126.
11. Mao-Qiang M, Elias PM, Feingold KR. Fatty acids are required for epidermal permeability barrier function. J Clin Invest 1993; 92: 791-798.
12. Mao-Qiang M, Brown BE, Wu-Pong S et al. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995; 131: 809-816.
13. Thornfeldt C. Critical and optimal molar ratios of key lipids. In: Lod́en M, Maibach HI, editors. Dry Skin and Moisturizers. CRC Press, Boca Raton, 2000: 337-347.
14. Berardesca E, Vignoli GP, Borroni G et al. Surfactant damaged skin: which treatment? In: Marks R, Plewig G, editors. The Environmental Threat to the Skin. Martin Duntiz, London, 1991: 283-285.